BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26459149)

  • 1. Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis.
    Zecca C; Disanto G; Sormani MP; Riccitelli GC; Cianfoni A; Del Grande F; Pravatà E; Gobbi C
    Mult Scler; 2016 May; 22(6):782-91. PubMed ID: 26459149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis.
    Ostini C; Bovis F; Disanto G; Ripellino P; Pravatà E; Sacco R; Padlina G; Sormani MP; Gobbi C; Zecca C
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33530366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord lesions are frequently asymptomatic in relapsing-remitting multiple sclerosis: a retrospective MRI survey.
    Granella F; Tsantes E; Graziuso S; Bazzurri V; Crisi G; Curti E
    J Neurol; 2019 Dec; 266(12):3031-3037. PubMed ID: 31494713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes.
    Yano H; Gonzalez C; Healy BC; Glanz BI; Weiner HL; Chitnis T
    Mult Scler Relat Disord; 2019 Oct; 35():119-127. PubMed ID: 31374460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
    Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.
    Dekker I; Sombekke MH; Witte BI; Geurts JJ; Barkhof F; Uitdehaag BM; Killestein J; Wattjes MP
    Mult Scler; 2018 Apr; 24(4):481-490. PubMed ID: 29106327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2 lesions and rate of progression of disability in multiple sclerosis.
    Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
    Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
    Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
    Neurology; 2018 Jul; 91(4):e349-e358. PubMed ID: 29950437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis.
    Lauerer M; McGinnis J; Bussas M; El Husseini M; Pongratz V; Engl C; Wuschek A; Berthele A; Riederer I; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
    J Neurol Neurosurg Psychiatry; 2023 Dec; 95(1):37-43. PubMed ID: 37495267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.
    Rotstein DL; Healy BC; Malik MT; Chitnis T; Weiner HL
    JAMA Neurol; 2015 Feb; 72(2):152-8. PubMed ID: 25531931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
    Stone LA; Cutter GR; Fisher E; Richert N; McCartin J; Ohayon J; Bash C; McFarland H
    J Neuroimaging; 2016 May; 26(3):296-302. PubMed ID: 26686343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis.
    Lim TRU; Kumaran SP; Suthiphosuwan S; Espiritu AI; Jones A; Lin AW; Oh J; Bharatha A
    Mult Scler; 2024 Apr; 30(4-5):505-515. PubMed ID: 38419027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
    Nayak NB; Salah R; Huang JC; Hathout GM
    Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study.
    Sechi E; Messina S; Keegan BM; Buciuc M; Pittock SJ; Kantarci OH; Weinshenker BG; Flanagan EP
    Mult Scler; 2021 Apr; 27(5):667-673. PubMed ID: 32552535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse.
    Miranda Acuña J; Hidalgo de la Cruz M; Ros AL; Tapia SP; Martínez Ginés ML; de Andrés Frutos CD
    Mult Scler Relat Disord; 2017 Nov; 18():157-160. PubMed ID: 29141800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
    Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
    JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.
    Minneboo A; Jasperse B; Barkhof F; Uitdehaag BM; Knol DL; de Groot V; Polman CH; Castelijns JA
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):917-23. PubMed ID: 18077480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.